- Home
- ANIP vs EVRI Comparison
ANIP vs EVRI Comparison
Compare ANIP & EVRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- EVRI
- Stock Information
- Founded
- ANIP 2001
- EVRI 1998
- Country
- ANIP United States
- EVRI United States
- Employees
- ANIP N/A
- EVRI N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- EVRI Services-Misc. Amusement & Recreation
- Sector
- ANIP Health Care
- EVRI Consumer Discretionary
- Exchange
- ANIP Nasdaq
- EVRI Nasdaq
- Market Cap
- ANIP 1.2B
- EVRI 1.2B
- IPO Year
- ANIP N/A
- EVRI 2005
- Fundamental
- Price
- ANIP $55.67
- EVRI $13.50
- Analyst Decision
- ANIP Buy
- EVRI Hold
- Analyst Count
- ANIP 7
- EVRI 5
- Target Price
- ANIP $77.33
- EVRI $12.88
- AVG Volume (30 Days)
- ANIP 253.7K
- EVRI 517.8K
- Earning Date
- ANIP 11-08-2024
- EVRI 12-24-2024
- Dividend Yield
- ANIP N/A
- EVRI N/A
- EPS Growth
- ANIP N/A
- EVRI N/A
- EPS
- ANIP N/A
- EVRI 0.15
- Revenue
- ANIP $555,456,000.00
- EVRI $760,419,000.00
- Revenue This Year
- ANIP $25.49
- EVRI N/A
- Revenue Next Year
- ANIP $19.92
- EVRI $5.06
- P/E Ratio
- ANIP N/A
- EVRI $90.30
- Revenue Growth
- ANIP 23.60
- EVRI N/A
- 52 Week Low
- ANIP $52.00
- EVRI $6.37
- 52 Week High
- ANIP $70.81
- EVRI $13.50
- Technical
- Relative Strength Index (RSI)
- ANIP 42.29
- EVRI 67.76
- Support Level
- ANIP $55.29
- EVRI $13.43
- Resistance Level
- ANIP $57.33
- EVRI $13.50
- Average True Range (ATR)
- ANIP 1.88
- EVRI 0.03
- MACD
- ANIP -0.16
- EVRI -0.00
- Stochastic Oscillator
- ANIP 5.34
- EVRI 93.75
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About EVRI Everi Holdings Inc.
Everi Holdings Inc provides entertainment and technology solutions for the casino, interactive, and gaming industry. It operates in two segments namely Games and Financial Technology Solutions (FinTech). Enveri Games provides gaming operators with gaming technology products and services which include gaming machines, slot machines, leased gaming equipment, and other products and services. Enveri FinTech provides gaming operators with financial technology products and services which include services and equipment that facilitate casino patron's to access cash at gaming facilities through automated teller machines, point of sale debit card purchases and others.